Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women

The American Journal of Cardiology

Volumn 69, Issue 3, 1992, Pages 176-178

  Hong, Mun K ^a   Romm, Philip A ^a   Reagan, Kathleen ^a   Green, Curtis E ^a   Rackley, Charles E ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTROGEN; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGED; CHOLESTEROL; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMAN; LIPIDS; MENOPAUSE; MIDDLE AGE; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 0026545837     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(92)91300-S     Document Type: Article

References (29)

1. Cardiovascular disease mortality among United States women
2. Epidemiology of coronary heart disease: the Framingham Study
3. Estrogen and coronary heart disease in women
4. A prospective study of postmenopausal estrogen therapy and coronary heart disease
5. Myocardial infarction and estrogen therapy in post-menopausal women
6. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham Study
7. Postmenopausal use of estrogen and occlusion of coronary arteries
8. An investigation of the age at menopause
9. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency
10. Quantitative determination of serum triglycerides by the use of enzymes
11. Quantification of highdensity-lipoprotein cholesterol by precipitation with phosphotungstic acid/ MgC12
12. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol: the Lipid Research Clinics Prevalence Study
13. Postmenopausal estrogen use and coronary atherosclerosis
14. Risk factors and noncontraceptive estrogen use in women with and without coronary disease
15. Angiographic progression of coronary artery disease and the development of myocardial infarction
16. Can coronary angiography predict the site of subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?
17. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity
18. High-density lipoprotein cholesterol and coronary artery disease; survey of the evidence
19. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women
20. Ischemic heart disease risk in postmenopausal women. Effects of estrogen use on glucose and insulin levels
21. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project
22. Estrogen modulates responses of atherosclerotic coronary arteries
23. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells
24. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women
25. Reduced efficacy of coronary bypass surgery in women
26. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA registry
27. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
28. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels: impact on the assessment of risk according to the National Cholesterol Education Program Guidelines
29. Within-person fluctuations of serum cholesterol and lipoproteins